The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. As the global voice of the sector, ARM represents the interests of 360+ members across 25 countries, including small and large companies, academic research institutions, major medical centers and patient groups.
Join 1,000+ of the sector’s top decisionmakers and senior executives for this virtual five-day conference featuring panels on a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies; presentations from nearly 120 of the leading public & private companies in the sector; and the meeting’s signature 1×1 partnering system!
Regenerative medicine includes gene therapies, cell therapies, and tissue-engineered products intended to augment, repair, replace, or regenerate organs, tissues, cells, genes, and metabolic processes in the body.
Regenerative medicine aims to alter the current practice of medicine by treating the root causes of disease and disorders.
ARM takes the lead on the most important issues facing the regenerative medicine and advanced therapy sector today:
ARM is a global community of therapeutic companies small & large, non-profit research institutions, patient organizations, and tool and technology providers. Working with our members and policymakers, we foster investment, research & development, and the successful commercialization of safe and effective treatments and cures for patients around the world.
